HCPLive

Top Medical News Today

Real-World Treatment Results with Ledipasvir-Sofosbuvir in Patients Coinfected with HIV and Hepatitis C
Researchers reported that SVR12 rates in real-world, post-transplant genotype 1 HCV patients treated with ledipasvir-sofosbuvir, with or without ribavirin, is 98% across regimens and various characteristics.
Researchers report promising results from the QUARTZ-I study that assessed the efficacy of the 3D regimen combined with sofosbuvir in treatment-experienced patients with HCV genotype 1 infection.
Results from the ION-3 trial showed that the rapidity and durability of viral suppression achieved with ledipasvir-sofosbuvir therapy allows a shorter treatment course of 8 weeks in genotype 1, treatment-naïve, non-cirrhotic patients.
As more women take leadership roles in gastroenterology and , it can go a long way in helping to bridge the gender gap in that other specialties in medicine.
As with many areas of medicine, the ratio of male doctors in gastroenterology to female counterparts is considerable – although work is being done to lessen that gap across the field.
Philip J. Mease, MD, and John D. Reveille, MD, outline the unmet needs and educational gaps in spondyloarthritis, including collaboration, under-diagnosis, and recognizing signs and symptoms.
John D. Reveille, MD, and Philip J. Mease, MD, provide insight on the evolution in classifying spondyloarthritis, including a review of the criteria.
With the month of May dedicated to skin cancer awareness, new research brings to light more cases of skin cancer being diagnosed than breast, colon, lung, and prostrate cancers combined.
Andrographis paniculata, available as an herbal medicine, helped patients with MS in a double-blind placebo-controlled study.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$